Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives
被引:16
|
作者:
Deb, Pran Kishore
论文数: 0引用数: 0
h-index: 0
机构:
Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, JordanPhiladelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
Deb, Pran Kishore
[1
]
Chandrasekaran, Balakumar
论文数: 0引用数: 0
h-index: 0
机构:
Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, JordanPhiladelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
Chandrasekaran, Balakumar
[1
]
Mailavaram, Raghuprasad
论文数: 0引用数: 0
h-index: 0
机构:
Sri Vishnu Coll Pharm, Pharmaceut Chem Div, Bhimavaram 534202, Andhra Pradesh, IndiaPhiladelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
Mailavaram, Raghuprasad
[2
]
Tekade, Rakesh Kumar
论文数: 0引用数: 0
h-index: 0
机构:
NIPER, Opposite Air Force Stn Palaj, Gandhinagar 382355, Gujarat, IndiaPhiladelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
Tekade, Rakesh Kumar
[3
]
Jaber, Abdul Muttaleb Yousef
论文数: 0引用数: 0
h-index: 0
机构:
Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, JordanPhiladelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
Jaber, Abdul Muttaleb Yousef
[1
]
机构:
[1] Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
[2] Sri Vishnu Coll Pharm, Pharmaceut Chem Div, Bhimavaram 534202, Andhra Pradesh, India
[3] NIPER, Opposite Air Force Stn Palaj, Gandhinagar 382355, Gujarat, India
Adenosine receptors (ARs) are classified as A(1), A(2A),A(2B), and A(3) subtypes belonging to the superfamily of G-protein-coupled receptors (GPCRs). Several molecular modeling approaches have been developed for A(2B)AR and its antagonists, from the construction of a homology model, molecular docking, molecular dynamics (MD) simulations, and 3D quantitative structure-activity relationship (QSAR) modeling to pharmacophore modeling, each of which has different objectives and outcomes. In this review, we provide a systematic outline of advances in molecular modeling approaches towards A(2B)AR for deducing its structure and interactions with various types of antagonist. The information, methods and perspectives presented here provides impetus for medicinal chemists to discover potential ligands that can bind selectively with higher affinity to A(2B)AR.